Tissuemed Seals Exit, with 41% IRR over 14 years

We are delighted to announce today the sale of Tissuemed to Becton Dickinson (NYSE: BDX).  Tissuemed, the Leeds-based medtech specialist, develops and manufactures self-adhesive films that help surgeons to close and seal sutured and stapled internal tissues. Tissuemed is the last of Shackleton's 2007 vintage investments to be sold.  It has achieved strong growth and profitability in recent years and has been paying dividends.  This [...]

2021-12-13T10:15:58+00:00December 9th, 2021|Categories: Exit, News|Tags: , , |

Tissuemed shortlisted for High Growth Exporter Award

Tissuemed has made it into year’s shortlist for the PD Ports Northern Powerhouse Export Awards 2018.  Tissuemed has been nominated in two categories, including the High Growth Exporter Award, in recognition of its great export success. Over the last 12 months, Tissuemed has received a number of awards following Chinese regulatory approval for the TissuePatch surgical sealant film family of products. David Mandley, CEO commented, [...]

2019-04-11T08:31:12+00:00February 9th, 2018|Categories: Awards, News|Tags: , |
Go to Top